Site intended for UK
audience
Site intended for UK
audience
Ibandronic acid Osteoviva® contains the active substance ibandronic acid.
Ibandronic acid Osteoviva® belongs to a group of medicines called bisphosphonates. Ibandronic acid Osteoviva® can counteract bone loss by stopping further bone loss and increasing bone mass in most women who take it. Ibandronic acid Osteoviva® can help reduce the risk of bone fractures.
Ibandronic acid Osteoviva® is used to treat osteoporosis in postmenopausal women at increased risk of fractures.
| Strength | Pack size |
| 3 mg | 1 (à 3 ml) |
We ask for your understanding that due to the Austrian Medicines Act, certain further information is only accessible to medical professionals.
Login
